Home › Funds › Catalio Capital Management, LP › MLYS

Catalio Capital Management, LP position in MLYS

Mineralys Therapeutics, Inc. · Health Care

Catalio Capital Management, LP reported holding 648,722 shares of MLYS (Mineralys Therapeutics, Inc.) in its Q2 2026 13F filing — a position valued at US$17.5M, representing 3.29% of its reported portfolio and ranking #12 among its reported holdings. Catalio Capital Management, LP has disclosed MLYS holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)648.72K sh
Reported value held$17.50M
Portfolio Weight3.29%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Catalio Capital Management, LP's MLYS position evolved

Catalio Capital Management, LP first disclosed a stake in MLYS in Q4 2025 at 331,849 shares (US$12.0M). The position peaked in Q2 2026 at 648,722 shares, worth US$17.5M. Across 3 filings, Catalio Capital Management, LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 648,722 shares valued at US$17.5M — an increase of 209,681 shares quarter over quarter.. Notable position changes include a 32% increase in Q1 2026 (shares were roughly flat over the following quarter), a 48% increase in Q2 2026 (shares fell 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 331.85K $12.04M New
Q1 2026 439.04K $11.89M Add
Q2 2026 648.72K $17.50M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MLYS and 13F data

MLYS (Mineralys Therapeutics, Inc.) is a Health Care company. 53 other funds we track also report a position in MLYS — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$207.6M), Catalys Pacific, LLC (US$196.0M), Samsara BioCapital, LLC (US$158.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MLYS

All MLYS fund holders →

FAQ

How long has Catalio Capital Management, LP held MLYS?

Catalio Capital Management, LP has disclosed MLYS holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Catalio Capital Management, LP's current position in MLYS?

As of Q2 2026, Catalio Capital Management, LP holds 648.72K shares of MLYS (Mineralys Therapeutics, Inc.), valued at $17.50M, representing 3.29% of its reported portfolio and ranking #12.

Has Catalio Capital Management, LP been buying or selling MLYS?

In the latest 13F filing (Q2 2026), Catalio Capital Management, LP increased its position in MLYS. The position peaked in Q2 2026 at 648.72K shares.

Which other funds hold MLYS?

Other major institutional holders of MLYS include RA CAPITAL MANAGEMENT, L.P., Catalys Pacific, LLC, Samsara BioCapital, LLC, among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.